SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-051135
Filing Date
2022-02-24
Accepted
2022-02-24 08:01:01
Documents
15
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d87894d8k.htm   iXBRL 8-K 27642
2 EX-99.1 d87894dex991.htm EX-99.1 45545
6 GRAPHIC g87894g0224033433566.jpg GRAPHIC 3391
7 GRAPHIC g87894g53d81.jpg GRAPHIC 4157
  Complete submission text file 0001193125-22-051135.txt   219339

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20220224.xsd EX-101.SCH 2878
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20220224_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20220224_pre.xml EX-101.PRE 11725
9 EXTRACTED XBRL INSTANCE DOCUMENT d87894d8k_htm.xml XML 3538
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 22666588
SIC: 2834 Pharmaceutical Preparations